NASDAQ:MNKD
MannKind Corporation Stock News
$4.82
+0 (+0%)
At Close: May 23, 2024
MannKind (MNKD) Looks Good: Stock Adds 5.5% in Session
12:30pm, Monday, 22'nd Jun 2020
MannKind (MNKD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Commonwealth Equity Services LLC Acquires 11,428 Shares of MannKind Co. (NASDAQ:MNKD)
04:38am, Monday, 22'nd Jun 2020
Commonwealth Equity Services LLC raised its holdings in shares of MannKind Co. (NASDAQ:MNKD) by 9.1% in the 1st quarter, Holdings Channel reports. The firm owned 136,377 shares of the biopharmaceutica
Afrezza Could Push MannKind Shares Higher, Says 5-Star Analyst
12:32am, Saturday, 20'th Jun 2020
Momentum is picking up for diabetes-focused biotech MannKind (MNKD). Shares surged 36% this week after MannKind’s presentation at the American Diabetes
Implied Volatility Surging for MannKind (MNKD) Stock Options
12:49pm, Thursday, 18'th Jun 2020
Investors need to pay close attention to MannKind (MNKD) stock based on the movements in the options market lately.
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
12:00am, Thursday, 18'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 17)
Adverum Biotechnologies Inc...
MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference
09:00pm, Wednesday, 17'th Jun 2020
MannKind Corporation (MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June
Why MannKind Shares Are Soaring Again Today | The Motley Fool
03:41pm, Wednesday, 17'th Jun 2020
Momentum is still in swing from the biotech's recent presentations.
Why MannKind Stock Is Crushing It Today | The Motley Fool
08:07pm, Monday, 15'th Jun 2020
Investors liked the biotech's presentations at a major diabetes conference.
WESTLAKE VILLAGE, Calif., June 15, 2020 -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza® (insulin human) Inhalation Powder was.
Investigator-Initiated Study Shows Switching to Afrezza® Improves Glucose Control with No Additional Hypoglycemia in T2DM
04:00pm, Saturday, 13'th Jun 2020
MannKind Corporation (MNKD) announced that data from a new clinical study of Afrezza® (insulin human) Inhalation Powder will be presented at the American Diabetes Association’s 80th Scientific Sess
MannKind: Stone Age Technology Isn't A Solution For Modern Day Medical Needs (NASDAQ:MNKD)
12:52pm, Saturday, 13'th Jun 2020
Readers will read about the updates for the Afrezza issues. I will discuss the impact of the hidden financial issue disclosed in the recent quarterly report. R
Investigator-Initiated Study Shows Switching to Afrezza® Improves Glucose Control with No Additional Hypoglycemia in T2DM
12:00am, Saturday, 13'th Jun 2020
WESTLAKE VILLAGE, Calif., June 13, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that data from a new clinical study of Afrezza®...
Hedge Funds Never Been Less Bullish On MannKind Corporation (MNKD)
05:10pm, Friday, 05'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
